What has emerged is that whereas some germline variants confer high risk for cancer due to disruption of gene function [13, 14], many BRCA1 and BRCA2 variants identified during routine genetic testing are determined to have little or no clinical significance with respect to cancer risk [4, 15, 16]. Here, BRCA2 is linked to cancer.